Posts Tagged ‘adalimumab’

August 20th, 2012

TNF Inhibitors Linked to Reduction in MI for Psoriasis Patients

Psoriasis patients who take TNF inhibitors have a significant reduction in the risk for myocardial infarction (MI), according to a retrospective cohort study published in Archives of Dermatology. Although previous research suggested that the anti-inflammatory effects of methotrexate, an older therapy, may be beneficial in this population, the cardiovascular effects of TNF inhibitors had not been […]